Developing a European Centre of Clinical Excellence for Pharmaceuticals

Document Type
AS

Cybersecurity Act

Document Type
AS

2030 Consumer Agenda

Document Type
AS
Adopted on 29/04/2026 - Bureau decision date: 28/04/2026
Reference
NAT/994-EESC-2026
Plenary session number
605
-
  • Record of proceedings NAT/994
Download — EESC opinion: Invalidation of allowances in the market stability reserve
Adopted on 29/04/2026 - Bureau decision date: 28/04/2026
Reference
NAT/992-EESC-2026
Plenary session number
605
-
  • Record of proceedings NAT/992
Download — EESC opinion: Equivalence of field inspections carried out in third countries on seed-producing crops and on the equivalence of seed produced in third countries

EPPO and OLAF access to VAT information at Union level
DG TAXUD – Commissioner HOEKSTRA

Apply AI Strategy – strengthening the AI continent
DG CNECT – Executive Vice-President VIRKKUNEN

Nuclear Illustrative Programme
DG ENER – Commissioner JØRGENSEN

Addressing loneliness: cementing measures for demographic cohesion
JRC – Commissioner ZAHARIEVA

Joint White Paper for European Defence Readiness 2030
Secretariat-General – President VON DER LEYEN